TY  - GEN
AU  - Lahtela,Heli
AU  - Rubboli,Andrea
AU  - Schlitt,Axel
AU  - Karjalainen,Pasi P
AU  - Niemelä,Matti
AU  - Vikman,Saila
AU  - Puurunen,Marja
AU  - Weber,Michael
AU  - Valencia,Josè
AU  - Biancari,Fausto
AU  - Lip,Gregory Y H
AU  - Airaksinen,K E Juhani
TI  - Heparin bridging vs. uninterrupted oral anticoagulation in patients with Atrial Fibrillation undergoing Coronary Artery Stenting. Results from the AFCAS registry
SN  - 1347-4820
PY  - 2012///1001
KW  - Administration, Oral
KW  - Aged
KW  - Aged, 80 and over
KW  - Angioplasty, Balloon, Coronary
KW  - adverse effects
KW  - Anticoagulants
KW  - administration & dosage
KW  - Atrial Fibrillation
KW  - complications
KW  - Coronary Artery Disease
KW  - Coronary Thrombosis
KW  - etiology
KW  - Drug Administration Schedule
KW  - Drug Substitution
KW  - Europe
KW  - Female
KW  - Hemorrhage
KW  - chemically induced
KW  - Heparin
KW  - Humans
KW  - Logistic Models
KW  - Male
KW  - Myocardial Infarction
KW  - Odds Ratio
KW  - Propensity Score
KW  - Prospective Studies
KW  - Registries
KW  - Risk Assessment
KW  - Risk Factors
KW  - Stents
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1253/circj.cj-11-1206
ER  -